← Evidence map

ArticleJAAD case reports2025

Ponatinib-induced psoriasis treated with tildrakizumab.

Kyle Mueller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40678003